Landauer Inc

Landauer — FY2012 Earnings Presentation

20 slides from Landauer's earnings presentation, Dec 11, 2012

  1. Slide 1: Fiscal 2012 Fourth Quarter and Year End Results

    LANDAUER, INC. Fiscal 2012 Fourth Quarter and Year End Results December 11 th , 2012

  2. Slide 2: Safe Harbor Statement

    2 Safe Harbor Statement Some of the information shared here (including, in particular, the section titled “Fiscal 2012 Outlook”) constitutes forward - looking statements that are based on assumptions and involve certain risks and uncertainties . These include the following, without limitation : assu

  3. Slide 3: Fiscal 2012 Fourth Quarter Highlights

    3  Consolidated revenue grew 23 percent to $37.4 million  Consolidated gross profit grew 14 percent to $20.3 million on increased revenue and mix  Radwatch System shipments of $2.7 million during the fourth quarter to the military and first responders markets  Medical Products segment contribute

  4. Slide 4: Fiscal 2012 Full Year Highlights

    4  Consolidated revenue grew 27 percent to $152.4 million  Consolidated gross profit grew 19 percent to $87.0 million on increased revenue and mix  Radwatch System shipments of $4.7 million during 2012 to the military and first responders markets  Medical Products segment contributed $13.5 milli

  5. Slide 5: Landauer Strategy Overview

    Value Creation Deliver Upside Growth 1. Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion Optimize the Core Competitive Growth  New Management/ Structure • Chief Financial Officer Q1’12 • Radiation Measurement Segment Q3‘12

  6. Slide 6: The Radiation Safety Continuum

    Therapeutic / Diagnostic Accessories Information Imaging Physics Therapy Physics Patient Monitoring Occupational Monitoring Consulting Strategic Expansion Existing Services with Penetration Opportunities* Complementary Adjacent Products / Services _____________________ (1) Average Revenue per Facili

  7. Slide 7: Addressable Markets

    Addressable Markets 2005 2010 2011 2012 Occupational Monitoring Radon Military Emergency Response Forensics Dose Reconstruction Patient Dose Consumer Radiation Radiation Markers Radiation Shielding Occupation Monitoring Radiation Instruments Radiation Measurements Patient Dose Information Management

  8. Slide 8: Competitive Growth: Expanding Global Military Relationships

    8 Competitive Growth Expanding Global Military Relationships  The U.S. military has now issued orders in excess of $20 million to upgrade its tactical dosimetry capabilities, and dosimetry laboratory • Radwatch system shipments in Q4’12 x $2.7 million primarily to the United States Military • FY 20

  9. Slide 9: Military and Emergency Response Market Opportunity

    Military and Emergency Response Market Opportunity  Expanding application of next generation technology to pursue global military and first responder radiation monitoring markets  The U.S. military has now issued orders in excess of $20 million to upgrade its tactical dosimetry capabilities, and d

  10. Slide 10: Strategic Expansion: Medical Physics

    10 Strategic Expansion Medical Physics  Medical Physics produced $7.8 million in revenues for fourth quarter 2012; represents growth of more than 30 percent from prior year period  Ongoing efforts to increase episodic premium services, leveraging a relatively fixed cost structure  Continued focus

  11. Slide 11: Nationally Recognized Top Health System

    Nationally Recognized Top 15 Health System 11 • Incremental Opportunity $2M • Strategy: - Verifii ™Quality Dashboards - C ontinued CEO Executive Sponsor Landauer Medical Physics Leadership and Oversight Across System: Physicist and Oncologist tied at the hip

  12. Slide 12: Strategic Expansion: Medical Products

    12 Strategic Expansion Medical Products  Medical Products segment generated revenues of $3.1 million for fourth quarter 2012  Operating income was $1.0 million with an operating margin 32.3 percent for fourth quarter 2012  Operating Income was $5.3 million with an operating margin 39.1 percent fo

  13. Slide 13: IZI Medical Market Map

    IZI Medical Market Map Spherz Radiation Therapy 13

  14. Slide 14: Optimize the Core: Systems Initiative Update

    14 Optimize the Core Systems Initiative Update  Went “Live” in July 2012  Full order to cash functionality ; Successful Full Year financial close September 2012  Substantial expense incurred throughout the fourth quarter 2012 in support of the stabilization of the system: – In fiscal 2012, $2.2 m

  15. Slide 15: LDR IT Evolution: 2006-2012

    LDR IT Evolution: 2006 - 2012 Applications (since 2007) Infrastructure (since 2007) • Customer Records - o ver 500M records migrated from IBM legacy system to new IT System platform • Data Center Co - location Strategy – implemented in FY12. Disaster Recovery / Risk Mitigation: total investment to d

  16. Slide 16: FY 2013 Outlook

    FY 2013 Outlook 16 Fiscal 2013 Outlook ▪ Expected Revenue $164 to $168 million, which includes a full fiscal year of contributions from the IZI Medical Products acquisition, versus 10.5 months in fiscal 2012 ▪ Adjusted EBITDA of $55 to $58 million ▪ Net Income of $21 to $23 million FY 2013 Outlook v

  17. Slide 17: FY 2013 Outlook vs. FY 2012 Actual: IT Platform Expenses

    FY 2013 Outlook vs. FY 2012 Actual New IT Platform Enhancement Expenses – Depreciation/ Steady State/ Customer Service / Implementation/ Stabilization expenses: • Total FY 2013 vs. FY 2012 $5.6M increased expense – Depreciation, additional $2.4M » Split between COG’s ($1.4M) and SG&A ($1.0M) – Ongoi

  18. Slide 18: Non-Cash Stock Based Compensation

    FY 2013 Outlook vs. FY 2012 Actual Non - Cash Stock Based Compensation – FY 2013 Forecast $3.6M – FY 2012 Actual $2.4M – Delta $1.2M 18

  19. Slide 19: Dividend Policy

    19 Dividend Policy Dividend Policy • Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the fourth quarter of fiscal 2012 – This represents an annual rate of $2.20 per share, consistent with fiscal 2011 levels – For the fourth fiscal quarter, the dividend was paid o

  20. Slide 20: Questions?

    Questions? Fiscal 2012 Fourth Quarter and Year End Results December 11 th , 2012

Landauer — FY2012 Earnings Presentation on 6ix